The Venture Codex Logo

The Venture Codex

Overview

Research and development of regenerative medicine for age-related diseases.

Founded

2009

Deals · 12mo

0

Links

Stage focus

Seed

Geographic focus

United States

Sector focus

Medical

Investment portfolio

  • Repair Biotechnologies

    Participated · Seed · May 2019

    Repair Biotechnologies is developing a pipeline of therapies focused on regenerating the thymus, treating cancer, and reversing atherosclerosis. The company aims to improve human healthspan by addressing underlying causes of aging and age-related diseases. Founded in 2018 by Reason (CEO) and Bill Cherman (Chairman), the company is based in Syracuse, N.Y. Repair is advancing programs in preclinical development. In July 2019 it raised $2.15M in seed funding to accelerate that preclinical work. The financing is intended to support the company’s near-term R&D and development milestones.

Insights

Team